D. Max Parkin

5.4k total citations · 1 hit paper
17 papers, 3.2k citations indexed

About

D. Max Parkin is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, D. Max Parkin has authored 17 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in D. Max Parkin's work include Global Cancer Incidence and Screening (10 papers), Colorectal Cancer Screening and Detection (9 papers) and Cervical Cancer and HPV Research (5 papers). D. Max Parkin is often cited by papers focused on Global Cancer Incidence and Screening (10 papers), Colorectal Cancer Screening and Detection (9 papers) and Cervical Cancer and HPV Research (5 papers). D. Max Parkin collaborates with scholars based in United Kingdom, France and Uganda. D. Max Parkin's co-authors include Freddie Bray, Andrew Hart, Kate Wooldrage, Rob Edwards, Stephen W. Duffy, John Northover, Jack Cuzick, Wendy Atkin, Ines Kralj‐Hans and Jane Wardle and has published in prestigious journals such as The Lancet, The Lancet Oncology and British Journal of Cancer.

In The Last Decade

D. Max Parkin

17 papers receiving 3.1k citations

Hit Papers

Once-only flexible sigmoidoscopy screening in prevention ... 2010 2026 2015 2020 2010 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Max Parkin United Kingdom 13 2.3k 908 904 604 594 17 3.2k
Mariano Santaquilani Italy 13 1.7k 0.7× 770 0.8× 448 0.5× 630 1.0× 436 0.7× 19 3.1k
Lawrence von Karsa France 24 3.3k 1.4× 1.4k 1.5× 1.3k 1.4× 771 1.3× 817 1.4× 36 4.8k
Rajaraman Swaminathan India 30 1.6k 0.7× 468 0.5× 935 1.0× 640 1.1× 308 0.5× 96 3.4k
Jae Kwan Jun South Korea 36 2.3k 1.0× 1.9k 2.0× 917 1.0× 1.4k 2.3× 351 0.6× 180 4.6k
Carmen Martos Spain 27 1.1k 0.5× 557 0.6× 1.0k 1.1× 630 1.0× 425 0.7× 111 3.3k
Cyllene R. Morris United States 26 1.7k 0.7× 434 0.5× 514 0.6× 448 0.7× 296 0.5× 60 2.9k
Russell B. McBride United States 30 1.5k 0.7× 595 0.7× 486 0.5× 790 1.3× 384 0.6× 80 3.4k
Thomas B. Richards United States 29 1.8k 0.8× 1.1k 1.2× 692 0.8× 432 0.7× 148 0.2× 75 3.1k
Henrike E. Karim‐Kos Netherlands 27 1.4k 0.6× 582 0.6× 396 0.4× 453 0.8× 379 0.6× 67 2.7k
Hyun‐Joo Kong South Korea 30 1.5k 0.7× 1.1k 1.2× 721 0.8× 981 1.6× 303 0.5× 45 3.8k

Countries citing papers authored by D. Max Parkin

Since Specialization
Citations

This map shows the geographic impact of D. Max Parkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Max Parkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Max Parkin more than expected).

Fields of papers citing papers by D. Max Parkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Max Parkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Max Parkin. The network helps show where D. Max Parkin may publish in the future.

Co-authorship network of co-authors of D. Max Parkin

This figure shows the co-authorship network connecting the top 25 collaborators of D. Max Parkin. A scholar is included among the top collaborators of D. Max Parkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Max Parkin. D. Max Parkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Andersson, Therése, Tor Åge Myklebust, Mark J. Rutherford, et al.. (2021). The impact of excluding or including Death Certificate Initiated (DCI) cases on estimated cancer survival: A simulation study. Cancer Epidemiology. 71(Pt A). 101881–101881. 12 indexed citations
2.
Morgan, Eileen, Melina Arnold, Mark J. Rutherford, et al.. (2021). The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non‐small cell lung cancer (ICBP SurvMark‐2 project). International Journal of Cancer. 149(5). 1013–1020. 10 indexed citations
3.
Andersson, Therése, Mark J. Rutherford, Tor Åge Myklebust, et al.. (2020). Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study. British Journal of Cancer. 124(5). 1026–1032. 17 indexed citations
4.
Cheng, Michael L., Li Zhang, Margaret Borok, et al.. (2015). The incidence of oesophageal cancer in Eastern Africa: Identification of a new geographic hot spot?. Cancer Epidemiology. 39(2). 143–149. 48 indexed citations
5.
Atkin, Wendy, Rob Edwards, Ines Kralj‐Hans, et al.. (2010). Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. The Lancet. 375(9726). 1624–1633. 1159 indexed citations breakdown →
6.
Parkin, D. Max, Jacques Ferlay, María Paula Curado, et al.. (2010). Fifty years of cancer incidence: CI5 I–IX. International Journal of Cancer. 127(12). 2918–2927. 192 indexed citations
7.
Parkin, D. Max & Freddie Bray. (2009). Evaluation of data quality in the cancer registry: Principles and methods Part II. Completeness. European Journal of Cancer. 45(5). 756–764. 385 indexed citations
8.
Bray, Freddie & D. Max Parkin. (2008). Evaluation of data quality in the cancer registry: Principles and methods. Part I: Comparability, validity and timeliness. European Journal of Cancer. 45(5). 747–755. 428 indexed citations
9.
Sitas, Freddy, D. Max Parkin, Mike Chirenje, et al.. (2008). Part II: Cancer in Indigenous Africans—causes and control. The Lancet Oncology. 9(8). 786–795. 66 indexed citations
10.
Parkin, D. Max, Freddy Sitas, Mike Chirenje, et al.. (2008). Part I: Cancer in Indigenous Africans—burden, distribution, and trends. The Lancet Oncology. 9(7). 683–692. 312 indexed citations
11.
Ekalaksananan, Tipaya, Chamsai Pientong, Supannee Sriamporn, et al.. (2006). Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening. Gynecologic Oncology. 103(1). 62–66. 28 indexed citations
12.
Bray, Freddie, Anja H. Loos, Peter McCarron, et al.. (2005). Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening. Cancer Epidemiology Biomarkers & Prevention. 14(3). 677–686. 285 indexed citations
13.
Newton, Robert U., John L. Ziegler, Edward Mbidde, et al.. (1998). HIV AND CANCER IN KAMPALA, UGANDA.. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 17(4). A12–A12. 4 indexed citations
14.
Ziegler, John L., Robert Newton, Kevin M. DeCock, et al.. (1997). RISK FACTORS FOR KAPOSI'S SARCOMA (KS) IN HIV SEROPOSITIVE SUBJECTS IN UGANDA. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14(4). A23–A23. 1 indexed citations
15.
Pontén, Jan, Reinhold Bergström, Joakim Dillner, et al.. (1995). Strategies for global control of cervical cancer. International Journal of Cancer. 60(1). 1–26. 249 indexed citations
16.
Balzi, Daniela, et al.. (1995). Cancer mortality in Italian migrants and their offspring in Canada. Cancer Causes & Control. 6(1). 68–74. 14 indexed citations
17.
Balzi, Daniela, et al.. (1994). Cancer Mortality in Italian Migrants to Canada. Tumori Journal. 80(1). 19–23. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026